RPP / GPP

Empowering better care through better pathogen detection.

 

Biovision Diagnostics offers Pathogen Panels that provide physicians and their patients with answers for the most common pathogens – viruses, bacteria, and parasites – that can lead to respiratory and gastrointestinal infections such as Influenza, Gastroenteritis, and other related conditions.

medical-biologic-testing-biovision-diagnostic

Clinical laboratories typically rely on the combination of conventional microbiological and molecular methods, which can often cause delays in the identification of pathogens.  For rapid identification of the pathogens, our multiplex front-line screening assays can be highly desirable and essential to facilitate the appropriate treatment of patients and reduce the inappropriate prescribing of antibiotic drugs.

WHAT MAKES OUR PATHOGEN PANELS BETTER?

HIGH-THROUGHPUT SYSTEM

Can process up to 188 patient samples per 8 hour shift

FDA-CLEARED ASSAYS

Any of our FDA-cleared assays can run simultaneously

FULLY-AUTOMATED PROCESS

Combines three testing steps into one, saving time and resources

IN-DEPTH DETECTION

Detects and identifies multiple bacterial, viral, and parasitic pathogen targets and subtypes

RAPID TURN-AROUND

Results provided within 24-48 hours to aid in pathogen diagnosis

PATIENT-SPECIFIC REPORTING

Data masking option enables select target reporting based on clinician’s order

Respiratory Pathogen Panel (RPP)

Biovision Diagnostics’ Respiratory Pathogen Panel (RPP) is a qualitative, multiplexed nucleic acid-based in vitro diagnostic test that simultaneously detects and identifies the presence of 17 respiratory pathogens in a single reaction.  The panel uses nasopharyngeal swab (NPS) samples obtained from individuals with signs and/or symptoms of respiratory tract infection.

The following pathogens and subtypes are identified:

Gastrointestinal Pathogen Panel (GPP)

Biovision Diagnostics’ Gastrointestinal Pathogen Panel (GPP) is a qualitative, multiplexed nucleic acid-based in vitro diagnostic test that simultaneously detects and differentiates the presence of 17 of the most-common diarrhea-causing (GI) pathogens. The samples are extracted directly from stool samples obtained from individuals with signs and/or symptoms of gastrointestinal infection.

The following bacteria, parasites, and viruses are identified: